Manojna Konda
Assistant Professor
faculty
College of Medicine Administration
Research Areas
Biography and Research Information
OverviewAI-generated summary
Manojna Konda is an Assistant Professor in the College of Medicine Administration at the University of Arkansas for Medical Sciences. Her research interests include hematologic malignancies, with publications focusing on multiple myeloma and aggressive NK-cell leukemia. Konda has investigated treatment strategies such as tandem autologous stem cell transplantation for minimal residual disease in multiple myeloma and analyzed population-based data on heavy chain disease incidence and outcomes. She has also contributed to research on cancer screening and prevention, examining sex and gender-based evidence in lung, breast, and colorectal cancers. Konda's work also extends to understanding risk factors for ischemic strokes in young adults and exploring novel therapeutic approaches for endocrine-resistant breast cancer.
Her scholarship metrics include an h-index of 6, with 48 total publications and 126 total citations. Konda has collaborated with several researchers at the University of Arkansas for Medical Sciences, including Anusha Jillella, Sravani Gundarlapalli, Akash Mukherjee, and Sharmilan Thanendrarajan, co-authoring multiple publications with them.
Metrics
- h-index: 6
- Publications: 47
- Citations: 129
Selected Publications
-
Cancer screening and prevention: Sex and gender evidence in lung, breast, and colorectal cancer (2026)
-
B-lymphoblastic leukemia/lymphoma with MYC and BCL2 gene rearrangements shows evidence for clonal evolution and mitotic recombination (2023)
-
Geographical distribution of prostate cancer clinical trials across the United States. (2022)
-
Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma (2022)
-
List of Contributors (2021)
-
Epidemiology of Aggressive NK-Cell Leukemia in the United States: A SEER Population-Based Study (2021)
-
Clinical-Laboratory- Genetic Profile and Outcomes of Patients with Atypical Hemolytic Uremic Syndrome and Restrictive Use of Eculizumab: A Single Center Experience and a Brief Review (2021)
-
Heavy Chain Disease in the United States: Analysis of Incidence, Patient Characteristics and Survival Outcomes (2021)
Collaboration Network
Top Collaborators
- Epidemiology of Aggressive NK-Cell Leukemia in the United States: A SEER Population-Based Study
- Heavy Chain Disease in the United States: Analysis of Incidence, Patient Characteristics and Survival Outcomes
- Clinical-Laboratory- Genetic Profile and Outcomes of Patients with Atypical Hemolytic Uremic Syndrome and Restrictive Use of Eculizumab: A Single Center Experience and a Brief Review
- Geographical distribution of prostate cancer clinical trials across the United States.
- Epidemiology of Aggressive NK-Cell Leukemia in the United States: A SEER Population-Based Study
- Heavy Chain Disease in the United States: Analysis of Incidence, Patient Characteristics and Survival Outcomes
- Clinical-Laboratory- Genetic Profile and Outcomes of Patients with Atypical Hemolytic Uremic Syndrome and Restrictive Use of Eculizumab: A Single Center Experience and a Brief Review
- Geographical distribution of prostate cancer clinical trials across the United States.
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Epidemiology of Aggressive NK-Cell Leukemia in the United States: A SEER Population-Based Study
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
- Epidemiology of Aggressive NK-Cell Leukemia in the United States: A SEER Population-Based Study
- Heavy Chain Disease in the United States: Analysis of Incidence, Patient Characteristics and Survival Outcomes
- Heavy Chain Disease in the United States: Analysis of Incidence, Patient Characteristics and Survival Outcomes
- Clinical-Laboratory- Genetic Profile and Outcomes of Patients with Atypical Hemolytic Uremic Syndrome and Restrictive Use of Eculizumab: A Single Center Experience and a Brief Review
- Epidemiology of Aggressive NK-Cell Leukemia in the United States: A SEER Population-Based Study
- Heavy Chain Disease in the United States: Analysis of Incidence, Patient Characteristics and Survival Outcomes
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
Similar Researchers
Based on overlapping research topics